Tectonic Therapeutic reported $231.1M in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Akebia Therapeutics USD 220.78M 8.77M Sep/2026
Alnylam Pharmaceuticals USD 5.11B 492.49M Sep/2026
Celltrion KRW 493.66B 12.09B Jun/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Divis Laboratories Ltd INR 124.39B 13.43B Sep/2026
Gilead Sciences USD 16.55B 4.02B Sep/2026
Ionis Pharmaceuticals USD 2.36B 129.77M Sep/2026
Kangmei Pharma CNY 6.66B 143.43M Jun/2026
Karyopharm Therapeutics USD 126.33M 23.19M Mar/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
MacroGenics USD 295.08M 26.61M Sep/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
Organigram Holdings CAD 280.09M 30M Jun/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pfizer USD 45.01B 3.65B Sep/2026
Pharma Mar EUR 295.56M 14.62M Sep/2026
Qiagen NV USD 1.66B 116.37M Jun/2026
Roche Holding CHF 35.44B 3.29B Jun/2026
Sangamo BioSciences USD 49.89M 12.3M Jun/2025
Sanofi EUR 33.21B 1.68B Sep/2026
Sarepta Therapeutics USD 2.27B 49.06M Sep/2026
Sartorius EUR 1.65B 8.4M Sep/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Takeda JPY 3T 153.11B Sep/2026
Tilray USD 729.32M 28.18M Sep/2025
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 13.48B 2.32B Sep/2026